METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER
Clinical trials for METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA combo for lung cancer trial pulled before it began
Disease control TerminatedThis study aimed to test a new mRNA treatment (CVHNLC) plus the immunotherapy drug pembrolizumab in people with advanced squamous non-small-cell lung cancer. The goal was to find a safe dose and see if adding chemotherapy later could help control the disease. However, the trial w…
Matched conditions: METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: CureVac • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
New hope for lung cancer: drug combo shows promise in Late-Stage trial
Disease control OngoingThis phase 3 study tests whether adding the drug INCMGA00012 to standard chemotherapy helps people with advanced non-small cell lung cancer live longer. About 583 participants with either squamous or nonsquamous lung cancer who have not had prior treatment will be enrolled. The s…
Matched conditions: METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC